choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

Taxotere Newsletter
  • Evolving Treatments and Advances in HER2-Positive Breast Cancer 20 Mar 2025 21:42 GMT

    … of treatment for this disease space, highlighting key trials in … (cancer-killing) drug, according to Nature Medicine. Essentially, Enhertu … a taxane (Taxol or Taxotere) with Herceptin and Perjeta … 3 CLEOPATRA trial established the first treatment to be …

  • Cancer Diaries: Developing needle phobia and dealing with seven-hour-long treatments 05 Mar 2025 04:30 GMT

    … with four different drugs in turn, namely docetaxel (Taxotere), carboplatin (Paraplatin), … not want to see a doctor ever again. At the … home and skip seeing the doctor was both assuming and … blood draws to come. Cancer treatments are like running a marathon …

  • ARASENS Trial: G-CSF Enables Full Docetaxel Dose in mHSPC 14 Feb 2025 02:49 GMT

    … ARASENS trial (NCT02799602), granulocyte colony stimulating factor (G-CSF) and docetaxel (Taxotere … both the darolutamide and placebo treatment groups except for geographic differences … 85% or less experienced more treatment-related adverse events (TRAEs) …

  • FDA Accepts Biologics License Application for Pertuzumab Biosimilar to Treat Breast Cancer 10 Feb 2025 21:09 GMT

    … ) and docetaxel (Taxotere; Hikma) is approved by the FDA to treat HER2 … , randomized, double-blind phase 3 trial (NCT05346224) included EU-sourced reference … /about-cancer/treatment/drugs/;pertuzumab 3. FDA approves combination of pertuzumab …

  • Breast cancer treatment side effect for women of color 27 Dec 2024 22:39 GMT

    … to Black women. Now, doctors are finding ways to … one of the drugs, a commonly used drug called Taxotere or docetaxel, … step in improving treatment and life after treatment because for some … an important conversation between the doctor and patient, but when …

  • Plights of Nigerians with cancer worsen as treatment costs soar 21 Dec 2024 09:32 GMT

    … of Radiology and Nuclear Medicine Consult Nigeria Limited (RANMED … a six-cycle treatment. Other treatments, such as docetaxel (Taxotere), cost around … . On average, chemotherapy drugs cost between N600,000 and … rest of my life. Doctors may consider me ‘cured’ …

  • I'm a pharmacist - here are the common medications that can cause hearing damage 20 Dec 2024 21:27 GMT

    …   2. Antidepressants  3. Anti-Seizure Drugs  4. Antimalarial Drugs  5. … treatment, studies have shown that common chemotherapy drugs … hearing. Taxane drugs include Taxol (paclitaxel) and Taxotere (docetaxel).… The last two medications Ms Gulzar highlights …

  • Doctors discover ways to reduce common side effect of chemotherapy 17 Dec 2024 17:27 GMT

    … after a couple of treatments, she developed neuropathy, a … of the drugs, a commonly-used drug called Taxotere or Docetaxel, … in improving treatment and life after treatment because for … important conversation between the doctor and patient. Copyright 2024 …

  • FDA Grants Breakthrough Therapy Designation to Sac-TMT for Previously Treated NSCLC 05 Dec 2024 14:45 GMT

    … TMT; Kelun Pharmaceutical, Merck) for the treatment of patients … 1 About the Trials TroFuse-004 Trial Name: Sacituzumab … (TROP2)-directed antibody drug conjugate (ADC) being developed … trial assessing sac-TMT compared with chemotherapy (docetaxel [Taxotere; …

  • FDA Approval of Trodelvy Withdrawn for Urothelial Carcinoma 22 Oct 2024 19:18 GMT

    Drug Administration (FDA) accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for the treatment … ’s choice of treatment, which included Taxol (paclitaxel), Taxotere (docetaxel) or … are more than 20 clinical trials in progress assessing Trodelvy as …

Satisfied with the content?

Continue to create your account.